These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 36066666)
1. A novel Fang J; Feng L; Meng L; Wang X; Liu H; Huang L; Zhang D; Li J; Zhuang R; Guo Z; Zhang X Eur J Nucl Med Mol Imaging; 2022 Dec; 50(1):27-37. PubMed ID: 36066666 [TBL] [Abstract][Full Text] [Related]
2. Fang J; Zhang J; Meng L; Li H; Xia D; Wang Y; Chen H; Liao Z; Zhuang R; Li Y; Zhang X; Guo Z Mol Pharm; 2024 Apr; 21(4):1942-1951. PubMed ID: 38447198 [TBL] [Abstract][Full Text] [Related]
3. Development of Liu H; Sun Y; Li J; Chen Y; Liu J; Fang J; Yang H; Feng L; Peng S; Zhuang R; Guo Z; Zhang X Mol Pharm; 2023 Jul; 20(7):3529-3538. PubMed ID: 37243620 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and Evaluation of [ Huang J; Bai L; Shi D; Jiang W; Chen P; Dong Y; Zhang X; Peng J; Hou J; Lu Y; Huang X; Tang G; Huang S Mol Pharm; 2024 May; 21(5):2425-2434. PubMed ID: 38554143 [TBL] [Abstract][Full Text] [Related]
5. Preclinical Evaluation of Fang J; Wang X; Meng L; Zhang J; Zhuang R; Li Y; Zhang X; Guo Z ACS Pharmacol Transl Sci; 2024 Jun; 7(6):1783-1794. PubMed ID: 38898942 [TBL] [Abstract][Full Text] [Related]
6. Automated Synthesis and Preclinical Evaluation of Optimized Integrin α6-Targeted Positron Emission Tomography Imaging of Pancreatic Cancer. Chen L; Fu H; He H; Lou K; Li Q; Ye J; Feng G; Yu C Mol Pharm; 2023 Aug; 20(8):4277-4284. PubMed ID: 37463487 [TBL] [Abstract][Full Text] [Related]
8. In Vivo Imaging of the Programmed Death Ligand 1 by González Trotter DE; Meng X; McQuade P; Rubins D; Klimas M; Zeng Z; Connolly BM; Miller PJ; O'Malley SS; Lin SA; Getty KL; Fayadat-Dilman L; Liang L; Wahlberg E; Widmark O; Ekblad C; Frejd FY; Hostetler ED; Evelhoch JL J Nucl Med; 2017 Nov; 58(11):1852-1857. PubMed ID: 28588151 [TBL] [Abstract][Full Text] [Related]
9. First (18)F-labeled ligand for PET imaging of uPAR: in vivo studies in human prostate cancer xenografts. Persson M; Liu H; Madsen J; Cheng Z; Kjaer A Nucl Med Biol; 2013 Jul; 40(5):618-24. PubMed ID: 23602763 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and Preclinical Evaluation of Folate-NOTA-Al(18)F for PET Imaging of Folate-Receptor-Positive Tumors. Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS Mol Pharm; 2016 May; 13(5):1520-7. PubMed ID: 27054811 [TBL] [Abstract][Full Text] [Related]
11. Pilot study of a novel (18)F-labeled FSHR probe for tumor imaging. Xu Y; Pan D; Zhu C; Xu Q; Wang L; Chen F; Yang R; Luo S; Yang M; Yan Y Mol Imaging Biol; 2014 Aug; 16(4):578-85. PubMed ID: 24389931 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo evaluation of a (18)F-labeled high affinity NOTA conjugated bombesin antagonist as a PET ligand for GRPR-targeted tumor imaging. Varasteh Z; Aberg O; Velikyan I; Lindeberg G; Sörensen J; Larhed M; Antoni G; Sandström M; Tolmachev V; Orlova A PLoS One; 2013; 8(12):e81932. PubMed ID: 24312607 [TBL] [Abstract][Full Text] [Related]
14. Improved stability of a novel fluorine-18 labeled TCO analogue for pretargeted PET imaging. Ruivo E; Adhikari K; Elvas F; Fissers J; Vangestel C; Staelens S; Stroobants S; Van der Veken P; Wyffels L; Augustyns K Nucl Med Biol; 2019; 76-77():36-42. PubMed ID: 31707309 [TBL] [Abstract][Full Text] [Related]
15. A novel aliphatic 18F-labeled probe for PET imaging of melanoma. Liu H; Liu S; Miao Z; Jiang H; Deng Z; Hong X; Cheng Z Mol Pharm; 2013 Sep; 10(9):3384-91. PubMed ID: 23927458 [TBL] [Abstract][Full Text] [Related]
16. STING-driven interferon signaling triggers metabolic alterations in pancreas cancer cells visualized by [ Liang K; Abt ER; Le TM; Cho A; Dann AM; Cui J; Li L; Rashid K; Creech AL; Wei L; Ghukasyan R; Rosser EW; Wu N; Carlucci G; Czernin J; Donahue TR; Radu CG Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34480004 [TBL] [Abstract][Full Text] [Related]
17. Gao F; Peng C; Zhuang R; Guo Z; Liu H; Huang L; Li H; Xu D; Wen X; Fang J; Zhang X Nucl Med Biol; 2019; 72-73():62-69. PubMed ID: 31330414 [TBL] [Abstract][Full Text] [Related]
18. Prostate cancer imaging of FSHR antagonist modified with a hydrophilic linker. Zhu C; Xu Q; Pan D; Xu Y; Liu P; Yang R; Wang L; Sun X; Luo S; Yang M Contrast Media Mol Imaging; 2016; 11(2):99-105. PubMed ID: 26286841 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and pre-clinical evaluation of a new class of high-affinity Kelly J; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Ponnala S; Babich JW Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):647-661. PubMed ID: 27847991 [TBL] [Abstract][Full Text] [Related]
20. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging. Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]